Literature DB >> 23743192

Orally active hypoglycemic protein from Costus igneus N. E. Br.: an in vitro and in vivo study.

Bimba N Joshi1, Hitendra Munot, Manasi Hardikar, Anjali A Kulkarni.   

Abstract

Plants have been used for the treatment of diabetes since time immemorial. In the present study, insulin-like protein (ILP) is purified from Costus igneus belonging to family Costaceae from Western ghats of India. The ILP showed cross reactivity with murine anti-insulin antibodies hence was purified by affinity chromatography using anti-insulin antibodies. The characterization of ILP showed that it is structurally different from insulin but functionally similar. The ILP showed a hypoglycemic activity in an in vitro assay with insulin responsive cell line RIN 5f. Interestingly ILP showed significant decrease in blood glucose level when administered orally in oral glucose tolerance test. This was compared to insulin a positive control given intraperitoneally in streptozotocine induced diabetic mice. There was no toxic effect seen on animals after administrating the ILP. Therefore we conclude that the ILP purified in the present study from C. igneus is a novel protein having hypoglycemic activity.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23743192     DOI: 10.1016/j.bbrc.2013.05.093

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  5 in total

Review 1.  Revisiting amino acids and peptides as anti-glycation agents.

Authors:  H Chilukuri; M J Kulkarni; M Fernandes
Journal:  Medchemcomm       Date:  2018-02-12       Impact factor: 3.597

2.  Association between dietary protein intake and type 2 diabetes varies by dietary pattern.

Authors:  Qiuyi Ke; Chaogang Chen; Li Cai; Min Xia; Fengyi He; Yongxin Ye; Xinxiu Bai
Journal:  Diabetol Metab Syndr       Date:  2018-06-15       Impact factor: 3.320

3.  An Insulin Receptor-Binding Multifunctional Protein from Tamarindus indica L. Presents a Hypoglycemic Effect in a Diet-Induced Type 2 Diabetes-Preclinical Study.

Authors:  Izael Costa; Mayara Lima; Amanda Medeiros; Lucas Bezerra; Paula Santos; Alexandre Serquiz; Maíra Lima; Gerciane Oliveira; Elizeu Santos; Bruna Maciel; Norberto Monteiro; Ana Heloneida Morais
Journal:  Foods       Date:  2022-07-25

4.  Increased insulin and GLUT2 gene expression and elevated glucokinase activity in β-like cells of islets of langerhans differentiated from human haematopoietic stem cells on treatment with Costus igneus leaf extract.

Authors:  Surekha Kattaru; Sunitha Manne Mudhu; Samundeshwari Echambadi Loganathan; Sireesha Kodavala; Venkata Gurunadha Krishna Sarma Potukuchi
Journal:  Mol Biol Rep       Date:  2021-06-09       Impact factor: 2.316

5.  In vitro and in vivo α-amylase and α-glucosidase inhibiting activities of the protein extracts from two varieties of bitter gourd (Momordica charantia L.).

Authors:  Sundar Poovitha; Madasamy Parani
Journal:  BMC Complement Altern Med       Date:  2016-07-18       Impact factor: 3.659

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.